Earnings season can make investing tricky. Many traders try to time trades based on earnings announcements, but usually find such trading is difficult and risky. It is often better to take a look ...
As explained in our education section, short interest is a useful sentiment indicator that measures the level of investor pessimism toward a stock. While it isn't always a simple "long only ...
Salix Pharmaceuticals announced financial and operating results for the fourth quarter and full year ended Dec. 31, 2009. In a release on March 9, Salix Pharmaceuticals noted that total product ...
Collective Brands Inc. (NYSE: PSS) decreased 4.96% to $22.80 in the pre-market session. The 52-week trading range for PSS is $7.11 - $24.31. PSS has gained over 38% in the last six months ...
US stocks closed higher Tuesday. The Dow Jones Industrial Average rose 12 points to 10564, the Standard & Poor's 500 gained 2 points to 1141 and the Nasdaq Composite Index climbed 8 points to 2341 ...
RALEIGH, NC--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced financial and operating results for the fourth quarter and full year ended December 31, 2009. ?We look ...
Salix posts narrower-than-expected Q4 loss - Reuters
Salix narrows 4Q loss on product sales - Forbes
MSN Money
- Benzinga
- RTT News
SLXP options saw interesting call activity today. A total of 222 put and 2,358 call contracts were traded raising a low Put/Call volume alert. Today's traded Put/Call ratio is 0.09. There were 10 ...
Salix Pharmaceuticals, Ltd. (SLXP - Analyst Report) is slated to report fourth quarter as well as fiscal 2009 results on March 9. The current Zacks Consensus Estimate for the fourth quarter of ...
by Elizabeth Harrow and Rocky White 3/4/2010 12:15 PM It's been quite a busy week for new highs in the stock market, with a number of equities exploring previously uncharted heights. One such ...
Salix Pharmaceuticals, Ltd. (SLXP) received good news recently when the Food and Drug Administration's (FDA) Gastrointestinal Drugs Advisory Committee recommended the approval of Xifaxan (500 mg ...
Morrisville, NC: The US Food and Drug Administration (FDA) recently weighed in on oral sodium phosphates (OSP) and acute phosphate nephropathy after receiving more than 20 reports of kidney damage ...
Below are the top 10 fastest-growing Pharmaceutical stocks, based on the average long-term earnings growth rate estimated by Wall Street analysts. Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) is ...
by EIN on 2010/02/25 (EMAILWIRE.COM, February 24, 2010 ) Dallas, Tx - Bowne & Co., Inc. (NYSE:BNE) soared 60% to $11.15 Printing services firm RR Donnelley & Sons Co (RRD.O) has agreed to acquire ...
(EMAILWIRE.COM, February 24, 2010 ) Dallas, Tx - US stocks extend its opening gain despite a midmorning report showed new home sales plunged 11.2% in January to a record low. However, Federal ...
USA 
